US Coronary Stents Market: Industry Analysis and Forecast (2024-2030)

The US Coronary Stents Market size was valued at USD 470 Million in 2023 and the total US Coronary Stents revenue is expected to grow at a CAGR of 3.55% from 2024 to 2030, reaching nearly USD 600 Million.

US Coronary Stents Market Overview

The US coronary stents market presents a dynamic landscape characterized by technological advancements, increasing prevalence, and significant implications for healthcare expenditure. The MMR report aims to analyse the current state and prospects of the US coronary stents market. It explores various segments of coronary stents, including Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, and emerging technologies. The US coronary stents market prevalence and incidence rates are on a steady rise. Current statistics by MMR reveal that coronary artery disease is a major health concern and causing 20% of US deaths in 2023. Atherosclerosis is the underlying cause and develops silently in childhood with fatty streaks. In the US, 14 million people suffer from coronary artery disease leading to complications like heart failure and 1.5 million annual heart attacks, with one-third proving fatal. The economic impact of coronary artery disease on healthcare expenditure in the US is significant and represents a substantial economic burden. The costs associated with CAD diagnosis, treatment, and post-complication care contribute to healthcare expenditure, emphasizing the need for effective preventive measures and cost-efficient management strategies. Additionally, indirect costs related to productivity loss and disability further amplify the economic impact of the US coronary stents industry.US Coronary Stents Market To know about the Research Methodology :- Request Free Sample Report Rising Prevalence of Cardiovascular Diseases Impact on the US Coronary Stents Market The increasing prevalence of cardiovascular diseases in the United States poses a public health concern and offers potential opportunities for the US coronary stents market. This prompts an exploration of the intricate connection between these seemingly unrelated phenomena. In the US, 14 million people suffer cardiovascular diseases in 2023 and leading to complications like heart failure and 1.5 million annual heart attacks, with one-third proving fatal. stand as a formidable public health crisis in the United States, claiming over 650,000 lives in 2023 and representing one-fourth of all deaths. Under the CVD umbrella, conditions such as coronary artery disease, stroke, heart failure, and arrhythmias disrupt vital cardiovascular functions, leading to life-threatening consequences. The prevalence of cardiovascular diseases is increasing and driven by factors such as an aging population, unhealthy lifestyle choices, and a growing burden of risk factors such as obesity, diabetes, and hypertension. The projections suggest that by 2030, almost 122 million Americans affected by at least one type of cardiovascular disease. This multifaceted threat requires comprehensive intervention strategies to address its complex determinants.US Coronary Stents Market1The increasing number of cardiovascular diseases in the US raises public health concerns but offers potential growth for the US coronary stents market. Meeting the demand for minimally invasive CAD interventions requires addressing healthcare costs, regulations, and competition for equitable access.

US Coronary Stents Market Segment Analysis

Based on Materials, the Metallic Stents segment held the largest market share of about 60% in the US Coronary Stents Market in 2023.  According to the MMR analysis, the segment is expected to grow at a CAGR of 3.12% during the forecast period. It stands out as the dominant segment within the US Coronary Stents Market thanks to its rapid technological advancement and growing adoption of smart devices with data connectivity and integration.US Coronary Stents Market2The US Coronary Stents metallic market anticipates moderate growth driven by rising coronary artery disease prevalence, an increasing geriatric population, and advancements in stent design. The persistent competition from bioresorbable stents, especially in specific patient segments, requires careful consideration based on factors such as patient anatomy and ongoing research developments. The metallic stents provide durable artery support, maintaining long-term openness with decades of successful clinical use, they demonstrate a reliable safety and efficacy history, often at a more economical cost compared to bioresorbable alternatives. Additionally, Long-term concerns arise with metallic stents due to their permanent implantation, posing challenges for future vessel imaging and procedures. Restenosis risk, though uncommon, involves tissue growth within the stent, possibly necessitating repeat procedures. Advances in bioresorbable stents address some limitations, influencing the US Coronary Stents Market share.

Global US Coronary Stents Market Scope: Inquire before buying

Global US Coronary Stents Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 470 Mn.
Forecast Period 2024 to 2030 CAGR: 3.55% Market Size in 2030: US $ 600 Mn.
Segments Covered: by Type Bare-metal Stents Drug-eluting Stents Bioabsorbable Stents
by Mode of Delivery Balloon-expandable Stents Self-expanding Stents
by Materials Metallic Stents Cobalt-Chromium Platinum Chromium Nickel Titanium Stainless Steel Other Stents
by End-User Hospitals Cardiac Centers Ambulatory Surgical Centers

Leading Key Players in the US Coronary Stents Market

1. Abbott Laboratories 2. Boston Scientific Corporation 3. Medtronic 4. Terumo Company 5. MicroPort Scientific Company 6. Biosensors International Group 7. Braun Melsungen AG 8. Biotronik SE & Co. KG 9. Stentys
1. US Coronary Stents Market Introduction 1.1 Study Assumption and Market Definition 1.2 Scope of the Study 1.3 Executive Summary 2. US Coronary Stents Market Overview 2.1 Emerging Technologies 2.2 Market Projections 2.3 Strategic Recommendations 3. US Coronary Stents Market: Dynamics 3.1.1 Market Drivers 3.1.2 Market Restraints 3.1.3 Market Opportunities 3.1.4 Market Challenges 3.2 PORTER’s Five Forces Analysis 3.3 PESTLE Analysis 3.4 Value Chain Analysis 3.5 Regulatory Landscape 3.6 Analysis of Government Schemes and Initiatives for the US Coronary Stents Industry 3.7 The Pandemic and Redefining of The US Coronary Stents Industry Landscape 4. US Coronary Stents Market: Market Size and Forecast by Segmentation (Value) (2023-2030) 4.1 US Coronary Stents Market Size and Forecast, by Type (2023-2030) 4.1.1 Bare-metal Stents 4.1.2 Drug-eluting Stents 4.1.3 Bioabsorbable Stents 4.2 US Coronary Stents Market Size and Forecast, by Mode of Delivery (2023-2030) 4.2.1 Balloon-expandable Stents 4.2.2 Self-expanding Stents 4.3 US Coronary Stents Market Size and Forecast, by Materials (2023-2030) 4.3.1 Metallic Stents 4.3.2 Cobalt-Chromium 4.3.3 Platinum Chromium 4.3.4 Nickel Titanium 4.3.5 Stainless Steel 4.3.6 Other Stents 4.4 US Coronary Stents Market Size and Forecast, by End-User (2023-2030) 4.4.1 Hospitals 4.4.2 Cardiac Centers 4.4.3 Ambulatory Surgical Centers 5. US Coronary Stents Market: Competitive Landscape 5.1 MMR Competition Matrix 5.2 Competitive Landscape 5.3 Key Players Benchmarking 5.3.1 Company Name 5.3.2 Service Segment 5.3.3 End-user Segment 5.3.4 Revenue (2023) 5.3.5 Company Locations 5.4 Leading UK Waste Management and Recycling Companies, by market capitalization 5.5 Market Structure 5.5.1 Market Leaders 5.5.2 Market Followers 5.5.3 Emerging Players 5.6 Mergers and Acquisitions Details 6. Company Profile: Key Players 6.1 Abbott Laboratories 6.1.1 Company Overview 6.1.2 Business Portfolio 6.1.3 Financial Overview 6.1.4 SWOT Analysis 6.1.5 Strategic Analysis 6.1.6 Scale of Operation (small, medium, and large) 6.1.7 Details on Partnership 6.1.8 Regulatory Accreditations and Certifications Received by Them 6.1.9 Awards Received by the Firm 6.1.10 Recent Developments 6.2 Boston Scientific Corporation 6.3 Medtronic 6.4 Terumo Company 6.5 MicroPort Scientific Company 6.6 Biosensors International Group 6.7 Braun Melsungen AG 6.8 Biotronik SE & Co. KG 6.9 Stentys 7. Key Findings 8. Industry Recommendations 9. Terms and Glossary 10. US Coronary Stents Market: Research Methodology